Safety and Risk of Pharmacotherapy

SJR Rank #26,648H-index: 5SJR: 0.135Best quartile: Q4Open AccessListed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

FSBI Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation

Country

Russian Federation

Type

journal

SJR by Edition

Only one SJR edition is available for this journal so far.

Subject Categories

  • Health Professions (miscellaneous)Q4
  • Pharmacology (nursing)Q4
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q4
  • PharmacyQ4

Areas: Health Professions · Nursing · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Pharmacovigilance and Adverse Drug ReactionsComputational Drug Discovery MethodsLegal and Regulatory AnalysisLinguistic, Cultural, and Literary StudiesMilitary Technology and StrategiesPharmaceutical studies and practicesPharmaceutical Economics and PolicyDrug-Induced Hepatotoxicity and ProtectionDrug-Induced Adverse ReactionsAcademic Publishing and Open Access

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0306090120

Documents per Year

Only one SJR edition is available for this journal so far.

Detailed Information

ISSN

2619-1164, 2312-7821

SJR Best Quartile

Q4

Region

Eastern Europe

Citations per Document (2 years)

0.44

References per Document

33.87

Coverage

2021-2025

Scope

No scope description available yet.

Metrics from SCImago Journal Rank 2025. View on SCImago